Raymond James & Associates’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-13,300
Closed -$9K 3566
2017
Q3
$9K Sell
13,300
-800
-6% -$47.7K ﹤0.01% 3355
2017
Q2
$45K Hold
14,100
﹤0.01% 3190
2017
Q1
$34K Buy
+14,100
New +$693K ﹤0.01% 3172

Other funds holding CONE

Raymond James & Associates's CONE Position: Q1 2022 in Review

Raymond James & Associates sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 202,597 shares — an estimated $18.2M sold.

Raymond James & Associates first reported a position in CONE in Q2 2013 and held it in 35 quarters. The position peaked at $62.1M in Q3 2018. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.

  • Raymond James & Associates reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
  • Raymond James & Associates sold 202,597 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $18.2M.
  • Raymond James & Associates first reported a position in CyrusOne Inc Common Stock in Q2 2013 and held it in 35 quarters.
  • Raymond James & Associates's CyrusOne Inc Common Stock position peaked at $62.1M in Q3 2018.
  • 3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.

Based on Raymond James & Associates's 13F filing for Q1 2022, filed 11 May 2022.